Anti-inflammatory Therapy in Rheumatoid Arthritis to Improve Cardiovascular Outcome

Can J Cardiol. 2020 Nov;36(11):1700-1702. doi: 10.1016/j.cjca.2020.03.023. Epub 2020 Mar 27.

Authors

Rabih R Azar¹, Marwan M Refaat²

Affiliations

¹ Division of Cardiology, Hotel Dieu de France Hospital the St Joseph University, Beirut, Lebanon. Electronic address: razar@usj.edu.lb.
² Division of Cardiology, American University Hospital and American University of Beirut, Beirut, Lebanon.

PMID: 32619444
DOI: 10.1016/j.cjca.2020.03.023

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anti-Inflammatory Agents / therapeutic use
Arthritis, Rheumatoid* / drug therapy
Biological Factors / therapeutic use
Cardiovascular Diseases* / epidemiology
Cardiovascular Diseases* / prevention & control
Cohort Studies
Humans
Tumor Necrosis Factor Inhibitors

Substances

Anti-Inflammatory Agents
Biological Factors
Tumor Necrosis Factor Inhibitors